Lucentis (Ranibizumab Injection) Drug Overview and Uses for Patients and Caregivers at RxList

Pill Identifier Search

May 27, 2012

Lucentis

Macular Degeneration »

Macular degeneration facts

The macula is in the center of the retina, the light-sensitive layer of tissue at the back of the eye. The macula is responsible for central vision (straight-ahead vision). Degeneration of the macula occurs most often after the age of 60 years and is termed age-related macular generation (AMD).
AMD is a painless condition.
There are two types of AMD: dry AMD and wet AMD.
Smoking, high blood pressure, obesity, a diet high in unsaturated fats and simple carbohydrates and lack of exercise all increase the risk of AMD.
Early symptoms of dry AMD include slightly blurred vision, the need for more light for reading, and difficulty recognizing faces until very close to the person. A symptom of more advanced dry AMD is the presence of a blurred spot in the center of vision. An early symptom of wet AMD is the wavy appearance of straight lines.
Dry AMD cannot be treated...

Read the Macular Degeneration article »

« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
Next »

Lucentis User Reviews >>

Lucentis

Eye Diseases and Conditions Slideshow Pictures

Pink Eye Slideshow Pictures

Cataracts Slideshow Pictures

font size

Lucentis Consumer

IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.

RANIBIZUMAB - INTRAOCULAR

(ra-ni-BIZ-oo-mab)

COMMON BRAND NAME(S): Lucentis

USES: This medication is used to treat a certain serious eye condition (age-related macular degeneration). It is used to help prevent decreased vision and blindness. Ranibizumab works by slowing the growth of abnormal new blood vessels in the eye and decreasing leakage from these blood vessels.

HOW TO USE: This medication is given by injection into the affected eye(s) by a health care professional. The affected eye is numbed before each injection. After the injection, you will remain in the doctor's office for a while, and your eye will be monitored.

Dosage is based on your medical condition and response to treatment. This medication is usually given once a month or as directed by your doctor. If you are not able to have monthly injections, your doctor may change your schedule after the first few injections to once every 3 months.

Use this medication regularly to get the most benefit from it.

Tell your doctor if your condition does not improve or if it worsens.